Novavax COVID Vaccine Clears Key Step on Path to FDA Authorization After Committee Endorses the Shot

Novavax’s two-dose dose COVID-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday.

The FDA’s committee of independent vaccine experts voted 21 to 0 with one abstention to recommend authorization of the shot for use in the U.S. after an all-day public meeting in which they weighed safety and effectiveness data. The FDA usually follows the committee’s recommendations, though it is not obligated to do so. The agency could clear Novavax’s vaccine for distribution in the U.S. as soon as this week.

The Centers for Disease Control Prevention would still need to sign off on the shots before pharmacies and other health-care providers can start administering them to people.

 

Source: www.cnbc.com/2022/06/07/novavax-covid-vaccine-clears-key-step-on-path-to-fda-authorization-after-committee-endorses-the-shot.html

Leave a Reply

Your email address will not be published.